These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6318302)

  • 21. Editorial: Varicella-zoster infections: zoster immune globulin.
    Hussey HH
    JAMA; 1974 May; 228(7):876. PubMed ID: 4362716
    [No Abstract]   [Full Text] [Related]  

  • 22. Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
    Paryani SG; Arvin AM; Koropchak CM; Wittek AE; Amylon MD; Dobkin MB; Budinger MD
    Am J Med; 1984 Mar; 76(3A):124-7. PubMed ID: 6324585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical reinfection with varicella-zoster virus.
    Gershon AA; Steinberg SP; Gelb L
    J Infect Dis; 1984 Feb; 149(2):137-42. PubMed ID: 6321605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to varicella-zoster virus glycoproteins I, II, and III in leukemic and healthy children.
    LaRussa PS; Gershon AA; Steinberg SP; Chartrand SA
    J Infect Dis; 1990 Sep; 162(3):627-33. PubMed ID: 2167335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay for antibodies in varicella-zoster virus serology.
    Trlifajova J; Pokorný J; Nĕmecek V; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):332-9. PubMed ID: 231068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing the properties of an experimental batch of zoster immune gammaglobulin (ZIG).
    Trlifajová J; Petera A; Ryba M; Pokorný J
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(1):42-50. PubMed ID: 93127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should patients with zoster receive zoster immune globulin?
    Uduman SA; Gershon AA; Brunell PA
    JAMA; 1975 Dec; 234(10):1049-51. PubMed ID: 171458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
    Harper DR; Grose C
    J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
    Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility to varicella-zoster virus in Thai children and young adults.
    Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I; Gershon AA; Steinberg SP; LaRussa P
    N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acyclovir and specific anti-varicella-herpes zoster immunoglobulins in the treatment of varicella-zoster virus infection in 113 adults].
    Senneville E; Chidiac C; Brouillard M; Beuscart C; Leroy O; Sivery B; Beaucaire G; Mouton Y
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):568-71. PubMed ID: 2166935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in antibody responses in varicella, herpes zoster and after vaccination.
    Kimoto T; Kurimura T
    Arch Virol; 1979; 59(1-2):59-67. PubMed ID: 218537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An algorithm for the control of nosocomial varicella-zoster virus infection.
    Weitekamp MR; Schan P; Aber RC
    Am J Infect Control; 1985 Oct; 13(5):193-8. PubMed ID: 2998229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives on vaccines against varicella-zoster virus infections.
    Gershon AA; Gershon MD
    Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Western blot analysis of antibody to varicella-zoster virus.
    Dubey L; Steinberg SP; LaRussa P; Oh P; Gershon AA
    J Infect Dis; 1988 May; 157(5):882-8. PubMed ID: 2834466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.